Hy-Vee implements controlled substance prescription policyHy-Vee's pharmacies are aiming to combat the opioid epidemic with a new controlled substance prescription policy. Braeburn's Brixadi gets tentative approvalBraeburn's Brixadi offers treatment for patients with moderate-to-severe opioid use disorder. Alembic gets approval for 2 generics The FDA has approved Alembic's generic Mirapex and Patanol, which had a market value of roughly $38.6 million, and $61 million, respectively. Sanofi, Merck get Vaxelis approval Sanofi and Merck received the FDA's approval for a new vaccine that will not have a commerical supply available in the United States prior to 2020. Lupin, AbbVie partner to develop cancer drugs Lupin and AbbVie have formed a partnership to develop Lupin's MALT1 inhibitors. Hikma, Sciecure Pharma ink deal for niche injectable anti-viral medicines Hikma expects its deal with Sciecure will expand its pipeline of niche products. FDA approves new Sprycel indication The Food and Drug Administration has given Bristol-Myers Squibb approval for a new pediatric indication for Sprycel. Slayback gets FDA nod for generic Makena The Food and Drug Administration has approved Slayback Pharma's generic Makena, which is available in a multidose vial. Learning the management side of business Susan Novotny-Cannata explains why attaining a PharmD and an MBA is a win-win situation for students and their employers. New York City pharmacies banned from selling cigarettes A bill signed by NYC Mayor Bill de Blasio in 2017 that prohibits New York City pharmacies from selling cigarettes and other tobacco products took effect Jan. 1. First Previous 560 561 562 563 564 Next Last
